Skip to main content

Prescription medicine

Dextrose, magnesium chloride and 4 other ingredients

Dextrose, magnesium chloride and 4 other ingredients is a prescription medicine with an FDA approval on record since 1979. No generic is listed in FDA's NDC Directory.

  • No generic listed

Check it at the source: the dextrose, magnesium chloride and 4 other ingredients FDA label on DailyMed (effective February 13, 2020, Baxter Healthcare Company); the NDA 17484 record on Drugs@FDA; every dextrose, magnesium chloride and 4 other ingredients label on DailyMed.

Highlights of the record

FDA label of February 13, 2020; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

5% Dextrose and Electrolyte No.

Forms and strengths

  • 5 g/100ml / 260 mg/100ml / 141 mg/100ml / 31 mg/100ml / 20 mg/100ml / 12 mg/100ml

Injection.

On the market

Earliest approval on file
February 2, 1979 Dextrose 5% And Electrolyte No. 48 In Plastic Container, Baxter Hlthcare; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
3 through July 30, 2026

What is dextrose, magnesium chloride and 4 other ingredients used for?

From the label: indications and usage

5% Dextrose and Electrolyte No. 48 Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) is indicated as a source of water, electrolytes, and calories or as an alkalinizing agent.

FDA pharmacologic class: Osmotic Laxative and Potassium Salt.

Source: FDA drug label (Dextrose and Electrolyte No. 48), Baxter Healthcare Company, effective February 13, 2020 (SPL set b283a454-0c20-4fbf-92d3-dae1f3cd3cad), via openFDA; the full label on DailyMed

Is there a generic for dextrose, magnesium chloride and 4 other ingredients?

No generic dextrose, magnesium chloride and 4 other ingredients is approved (Drugs@FDA, October 8, 2026).

  • 1979 earliest approval on file

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What does the dextrose, magnesium chloride and 4 other ingredients label say about other medicines?

The dextrose, magnesium chloride and 4 other ingredients label names 4 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Corticotropindrug interactionsAvoid use of 5% Dextrose and Electrolyte No. 48 Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) in patients receiving such products, such as corticosteroids or corticotropin.
Cyclosporinedrug interactions… sparing diuretics, ACE inhibitors, angiotensin II receptor antagonists, or the immunosuppressants tacrolimus and cyclosporine.
Lithiumdrug interactionsLithium Renal clearance of lithium may be increased during administration of 5% Dextrose and Electrolyte No. 48 Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP).
Tacrolimusdrug interactions… potassium sparing diuretics, ACE inhibitors, angiotensin II receptor antagonists, or the immunosuppressants tacrolimus and cyclosporine.

Check dextrose, magnesium chloride and 4 other ingredients against other medicines

Source: FDA drug label (Dextrose and Electrolyte No. 48), Baxter Healthcare Company, effective February 13, 2020 (SPL set b283a454-0c20-4fbf-92d3-dae1f3cd3cad), via openFDA; the full label on DailyMed

What do FAERS reports show for dextrose, magnesium chloride and 4 other ingredients?

The FDA Adverse Event Reporting System holds 3 reports that list dextrose, magnesium chloride and 4 other ingredients among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 0 are coded as a death and 3 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Pneumonia2
  • Capillary Leak Syndrome1
  • Covid-191
  • Febrile Neutropenia1
  • Respiratory Failure1
  • Sepsis1
  • Septic Shock1

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Other osmotic laxatives
the pharmacologic class, with prices and generics
Check an interaction
what two or more labels say about each other